18.60SEK+0.22%Mkt Cap: 649.15M SEKP/E: —Last update: 2026-05-13
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products in…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-4.32
PEG13.07
P/B1.78
P/S36.47
EV/EBITDA-0.89
EV/Revenue15.16
EPS (TTM)-12.02
EPS (Forward)-4.28
Cash Flow & Leverage
FCF Yield-0.02%
FCF Margin-0.84%
Operating CF-195.40M SEK
CapEx (TTM)—
Net Debt/EBITDA1.25
Net Debt-379.20M SEK
Technical
SMA 5021.11 (-11.9%)
SMA 20026.40 (-29.6%)
Beta0.87
S&P 52W Chg24.23%
Avg Vol (30d)48.99K
Avg Vol (10d)27.10K
Technical Indicators
RSI (14)38.0
MACD-0.9401
MACD Signal-1.0080
MACD Hist.+0.0680
BB Upper21.48 SEK
BB Middle19.47 SEK
BB Lower17.47 SEK
BB Width20.57%
ATR (14)1.003 SEK
Vol Ratio (20d)0.11x
52W Range
13.5617% of range43.40
52W High43.40 SEK
52W Low13.56 SEK
Profitability
Gross Margin44.23%
EBITDA Margin0.00%
Profit Margin2458.85%
Oper. Margin-1514.00%
ROE130.31%
ROA49.07%
Revenue Growth-62.10%
Earnings Growth—
Balance Sheet
Debt/Equity1.00
Current Ratio2.02
Quick Ratio1.97
Book Value/Sh10.38 SEK
Cash/Share10.99 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.35.13M
Float21.45M
Insiders18.89%
Institutions40.28%
Analyst Consensus
Rating—
Target (Mean)27.00 SEK
Target Range27.00 SEK – 27.00 SEK
# Analysts1
Company
Market Cap649.15M SEK
Enterprise Value269.94M SEK
Revenue (TTM)17.80M SEK
Gross Profit11.50M SEK
Net Income (TTM)639.30M SEK
Revenue/Share0.5120 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
Last Price18.60 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—